SCHEMBL2085552

SCHEMBL2085552

N#CC1(N)CCSCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL971234 0.97
SCHEMBL6765230 0.84
SCHEMBL696010 0.78
Hydrochloric Acid SCHEMBL345144 0.76
Hydrochloric Acid SCHEMBL1201605 0.76 ALDH1A1 (0.30)
SCHEMBL75984 0.73
Hydrochloric Acid SCHEMBL1273427 0.73
SCHEMBL1139426 0.73
SCHEMBL14941325 0.72
SCHEMBL23311387 0.71 ALDH1A1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024114762-A1 POLYPEPTIDE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2024-06-06 WO disclosed
US-20240083917-A1 Polycyclic Kinase Inhibitor Xuanzhu Biopharmaceutical Co., Ltd. (CN) 2024-03-14 US disclosed
EP-4289853-A1 POLYCYCLIC KINASE INHIBITOR Shandong Xuanzhu Pharma Co., Ltd. (CN) 2023-12-13 EP disclosed
CN-116669741-A Polycyclic kinase inhibitors 山东轩竹医药科技有限公司 2023-08-29 CN disclosed
WO-2022148354-A1 POLYCYCLIC KINASE INHIBITOR 山东轩竹医药科技有限公司 2022-07-14 WO disclosed
WO-2022148354-A1 POLYCYCLIC KINASE INHIBITOR 山东轩竹医药科技有限公司 2022-07-14 WO disclosed
EP-2763976-B1 2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS MERCK SHARP & DOHME (US) 2016-05-18 EP disclosed
US-9216173-B2 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors MERCK SHARP & DOHME CORP. (US) 2015-12-22 US disclosed
EP-1663958-B1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2015-02-25 EP disclosed
US-8921380-B2 Pyrazolo[1,5-a] pyrimidine compounds as CB1 receptor antagonist MITSUBISHI TANABE PHARMA CORPORATION (JP) 2014-12-30 US disclosed
US-5646172-A Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle ROUSSEL UCLAF (FR) 1997-07-08 US disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
US-5552419-A METALLOPROTEINASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-09-03 US disclosed
US-5512681-A HORMONE INHIBITORS FOR TREATMENT OF HYPERTENSION OR CONGESTIVE HEART FAILURE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1996-04-30 US disclosed
US-5506242-A METALLOELASTASE INHIBITOR; TREATS EMPHYSEMA CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
EP-0704448-A1 Heterocyclic substituted imidazolidines, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them ROUSSEL UCLAF (FR) 1996-04-03 EP disclosed
US-5455258-A Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase CIBA-GEIGY CORPORATION (US) 1995-10-03 US disclosed
EP-0606046-A1 Arylsulfonamido-substituted hydroxamic acids CIBA-GEIGY AG (CH) 1994-07-13 EP disclosed
EP-0601039-A1 ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLINONE DERIVATIVES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1994-06-15 EP disclosed
WO-1993004046-A1 ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLINONE DERIVATIVES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-03-04 WO disclosed